|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits with banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities available for sale, at fair value | ||||||||||||||||||||
| Investment securities held to maturity, at amortized cost (fair value of $1,267,546 and $1,647,360, respectively) | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Restricted stock, at cost | ||||||||||||||||||||
| Mortgage loans held for sale, at fair value | ||||||||||||||||||||
| Other loans held for sale | ||||||||||||||||||||
| Loans receivable (net of allowance for loan losses of $18,964 and $12,975, respectively) | ||||||||||||||||||||
| Loans receivable (net of allowance for credit losses of $25,255 and $18,964, respectively) | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Operating lease right-of-use asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Demand - non-interest bearing | ||||||||||||||||||||
| Demand - interest bearing | ||||||||||||||||||||
| Money market and savings | ||||||||||||||||||||
| Time deposits | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Short-term borrowings | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and contingencies (see note 4) | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Preferred stock, par value $0.01 per share; liquidation preference $25.00 per share; 10,000,000 shares authorized; shares issued 1,471,000 as of September 30, 2022 and 2,000,000 as of December 31, 2021; shares outstanding 1,471,000 as of September 30, 2022 and 2,000,000 as of December 31, 2021 | ||||||||||||||||||||
| Common stock, par value $0.01 per share: 100,000,000 shares authorized; shares issued 64,315,909 as of September 30, 2022 and 59,471,998 as of December 31, 2021; shares outstanding 63,787,064 as of September 30, 2022 and 58,943,153 as of December 31, 2021 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock at cost (503,408 shares as of September 30, 2022 and December 31, 2021) | ||||||||||||||||||||
| Stock held by deferred compensation plan (25,437 shares as of September 30, 2022 and December 31, 2021) | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Shareholders’ Equity |
Loading...
